Sajankumar R. Bajaj has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sajankumar R. Bajaj, along with the promoter group and persons acting in concert, has filed the annual disclosure under SEBI's Takeover Regulations for FY 2025-26. As on March 31, 2026, the promoter group collectively holds 1,96,22,885 equity shares of Bajaj Healthcare Limited, of which 9,10,148 shares are still pending listing on stock exchanges. The promoter has confirmed that no encumbrance (pledge, lien, or charge) was created on any of the shares held, directly or indirectly, during the financial year. The promoter group includes Babita Bajaj, Namrata Bajaj, Nihita Bajaj Kumar, Anil Champalal Jain, Padma Anil Jain, Bansal Pharma Limited, and Bajaj Health & Nutritions Private Limited.
This is a routine annual SEBI compliance filing and is not expected to have any direct impact on the stock price. The no-encumbrance confirmation is a neutral-to-positive signal for shareholders, indicating the promoter group is not under financial stress. However, investors should note that 9.10 lakh shares awaiting listing could eventually add to the floating supply.